Global Bioprocess Technology Market 2022-2026

Global Bioprocess Technology Market 2022-2026

Technavio has been monitoring the bioprocess technology market and it is poised to grow by $ 55.84 bn during 2022-2026, accelerating at a CAGR of 12.27% during the forecast period. Our report on the bioprocess technology market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by an increase in infectious diseases, an increase in chronic diseases, and growing healthcare expenditure in developing countries.

The bioprocess technology market analysis includes the end-user segment and geographic landscape.

Technavio's bioprocess technology market is segmented as below:

By End-user

• Biopharmaceutical companies
• Contract manufacturing organizations
• Academic research institute
• Others

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the increasing clinical trials in countries as one of the prime reasons driving the bioprocess technology market growth during the next few years. Also, an increase in M&A activities by vendors and increasing demand for 3D cell culture will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the bioprocess technology market covers the following areas:

• Bioprocess technology market sizing
• Bioprocess technology market forecast
• Bioprocess technology market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading bioprocess technology market vendors that include Advanced Instruments LLC, Becton Dickinson and Co., Boehringer Ingelheim International GmbH, Catalent Inc., Charles River Laboratories International Inc., Corning Inc., Dover Corp., Emerson Electric Co., Fujifilm Diosynth Biotechnologies USA Inc., General Electric Co., Koninklijke Philips NV, Lonza Group Ltd., Merck KGaA, Nova Biomedical Corp., Repligen Corp., Sartorius AG, STADA Arzneimittel AG, Thermo Fisher Scientific Inc., Univercells SA, and Eppendorf AG. Also, the bioprocess technology market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.